AS

Alo Sengupta

Active Director Director DIN 00817569
DIN 00817569 First appointment Dec 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Alo Sengupta

Data last updated:

Alo Sengupta is a Director at Nephro Care India Limited (since 2023). The company operates in Healthcare.

DIN 00817569
Primary Designation Director
Industry Healthcare
First Appointment 26 Dec 2023
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nephro Care India Limited L85100WB2014PLC202429
Director26 Dec 20232014Active

Board colleagues of Alo Sengupta

Directorship timeline

Open interactive timeline →
Nephro Care India Limited
Premium access

Shareholding and investment profile for Alo Sengupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alo Sengupta

Alo Sengupta currently holds 1 directorship: Nephro Care India Limited (Director, since 26 Dec 2023).

Alo Sengupta was first appointed on 26 Dec 2023 as Director at Nephro Care India Limited.

The current boards of Alo Sengupta's companies include Debashish Ghoshal (Nephro Care India Limited), Pratim Sengupta (Nephro Care India Limited), Pritam Sengupta (Nephro Care India Limited), Saikat Biswas (Nephro Care India Limited), Sandeep Shridhar Ghate (Nephro Care India Limited), Sougata Sengupta (Nephro Care India Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available